PROTAMINE
Cardiopulmonary Bypass
University Hospital, Strasbourg, Franceprotein_peptidePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Cardiopulmonary Bypass cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
HEPARIN University Hospital, Strasbourg, France | Phase 4 | BB |
Acadesine Merck Sharp & Dohme LLC | Phase 3 | B |
PROPOFOL Johns Hopkins University | N/A | D |
ISOFLURANE Johns Hopkins University | N/A | D |
Same molecule, other indications
PROTAMINE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →